WO2001085250A1 - Transcutaneous energy transfer with circuitry arranged to avoid overheating - Google Patents
Transcutaneous energy transfer with circuitry arranged to avoid overheating Download PDFInfo
- Publication number
- WO2001085250A1 WO2001085250A1 PCT/US2001/015152 US0115152W WO0185250A1 WO 2001085250 A1 WO2001085250 A1 WO 2001085250A1 US 0115152 W US0115152 W US 0115152W WO 0185250 A1 WO0185250 A1 WO 0185250A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coil
- circuitry
- magnetic flux
- subcircuits
- secondary coil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
- A61M60/873—Energy supply devices; Converters therefor specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging
- A61M60/875—Energy supply devices; Converters therefor specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging specially adapted for optimising alignment of external and implantable coils
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J50/00—Circuit arrangements or systems for wireless supply or distribution of electric power
- H02J50/10—Circuit arrangements or systems for wireless supply or distribution of electric power using inductive coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3317—Electromagnetic, inductive or dielectric measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8237—Charging means
- A61M2205/8243—Charging means by induction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J2310/00—The network for supplying or distributing electric power characterised by its spatial reach or by the load
- H02J2310/10—The network having a local or delimited stationary reach
- H02J2310/20—The network being internal to a load
- H02J2310/23—The load being a medical device, a medical implant, or a life supporting device
Definitions
- the invention relates to the transfer of electromagnetic energy between a primary coil located outside the skin and a secondary coil located beneath the skin. More specifically, the invention concerns the circuitry used in connection with the secondary coil to condition the electromagnetic energy into a useful form.
- Implanted medical devices are powered by electricity. Some devices, such as artificial pacemakers, may be battery-powered because their power requirements are comparatively low. Other devices require considerably more power and cannot be adequately supplied by a battery on a long-term basis.
- An implantable blood pump for example, requires considerably more power than an ordinary pacemaker. A pacemaker rhythmically generates electrical impulses to stimulate the heart muscle, but the pacemaker does not perform any mechanical pumping action. An implantable blood pump, by contrast, mechanically assists the heart muscle to pump blood, and for this reason has a considerably greater power requirement.
- Power requirements for a typical pacemaker may be on the order of 10 milliwatts, as compared with an implantable blood pump, which may have a power requirement one thousand times greater.
- Implantable electric storage batteries are unable to provide such power for long periods of time, and the frequent invasive surgery that would be required to replace the batteries makes this option undesirable. If the implantable batteries are rechargeable, then the batteries must be recharged from time to time, and power must in some way be delivered to recharge the batteries. Once again, use of invasive surgery to deliver the recharge is not a desirable alternative.
- the power source for a high-power device must be external to the body. To deliver the power to the device, the power must somehow transit through the skin. Power may be delivered through the skin by a percutaneous wire, but this method has drawbacks. A wire penetrating the skin provides a source for infection. Moreover, there is a risk that a wire penetrating the skin may accidentally be torn out, which may cause loss of power to the device and trauma to the patient.
- TET transcutaneous energy transfer
- Faraday's Law holds that the electromotive force (emf) in a conducting coil of N turns and the rate of change of magnetic flux through the coil are related.
- the negative sign is a matter of convention, and is indicative of the direction of the induced emf.
- Both the current in the primary coil and the current induced in the secondary coil are time- varying.
- Direct current (dc) will not result in a time-varying magnetic flux, and therefore will not create mutual induction.
- the current or voltage in the secondary coil must be conditioned for use by the device. Ordinarily, conditioning includes such functions as rectifying the current or voltage, filtering it to remove high-frequency components, and regulating it to provide substantially constant amounts of current or voltage.
- the present invention is directed to a transcutaneous energy transfer system having a secondary coil with integrated power conditioning circuitry.
- the transcutaneous energy transfer system may be particularly useful with an implantable blood pump having a pump control module.
- the pump control module ordinarily is implanted in the abdomen. Integration of the power conditioning circuitry with the secondary coil permits immediate conversion of energy induced at the secondary coil to dc current, instead of at the pump control module. Consequently, thinner leads can be used to couple the secondary coil to the pump control module, thus enhancing system versatility by expanding sites available for module implantation.
- the secondary coil and power conditioning circuitry can be arranged to provide a relatively low profile for implantation, while also limiting the generation of eddy currents in the power conditioning circuitry.
- Eddy currents in the power conditioning circuitry may be created when the circuitry is in proximity to the time- varying magnetic flux generated by the primary coil. A reduction in the generation of eddy currents helps avoid the creation of excessive heat in the area of the secondary coil, and resulting inflammation of nearby tissue.
- the power conditioning circuitry can be mounted within the aperture defined by the secondary coil with a structure and orientation designed to avoid coincidence with magnetic flux lines extending substantially perpendicular to the major plane defined by the secondary coil.
- power-conditioning circuitry is constructed as a substantially planar package or module.
- the circuitry may be placed on one or more circuit boards mounted within the aperture defined by the secondary coil and may be electrically connected to the secondary coil such that time- varying currents induced in the secondary coil are delivered to the conditioning circuitry.
- the conditioning circuitry may be encased in a non-conductive medium, the conditioning circuitry and circuit board may consist of conductors and semiconductors.
- the planar circuitry is oriented to reside within the coil aperture and occupy the major plane defined by the coil.
- Placement of the conditioning circuitry inside the secondary coil may have significant space-saving advantages, but may pose practical difficulties.
- the time- varying magnetic flux generated by the primary coil ordinarily will induce some time- varying eddy currents, in addition to the current induced within in the secondary coil.
- the present invention provides a way for the circuitry to be mounted within the secondary coil yet minimize eddy currents and thereby reduce the risk of excessive heating.
- TET systems may be in many forms, and the orientation of the lines of magnetic flux may be estimated. Where the primary and secondary coils are substantially circular and are axially aligned, for example, the location lines of magnetic flux can be reasonably estimated, especially along the diameters and near the centers of the coils.
- the circuitry attendant to the secondary coil may be substantially planar, and may be placed so that the plane of the circuitry is substantially tangent to the lines of magnetic flux.
- the lines of magnetic flux may pass through the major plane of the secondary coil at near-right angles, and magnetic flux lines near the center of the secondary coil's aperture may be substantially parallel to the secondary coil's axis.
- the present invention generally provides a device for use in transcutaneous energy transfer, comprising a coil for subcutaneous placement, and substantially planar circuitry electrically connected to the coil, wherein the plane of the circuitry is oriented substantially tangent to the lines of magnetic flux.
- the plane of the circuitry preferably is oriented substantially perpendicular to the major plane of the coil to minimize creation of eddy currents within the circuitry.
- the circuitry can be divided into sub-planes that are mounted adjacent one another in a stacked relationship.
- the circuitry may include two or more circuit planes with surface-mounted components that form a multi-plane circuit package, e.g., a "double-decker” or “triple-decker” arrangement.
- the circuit package may provide multiple interlocking circuit planes.
- the electrical components necessary for conditioning are distributed among two or more circuit planes, which may be individual printed circuit board sections.
- the circuitry may take on a curved shape. In this manner, the surface area and resulting height of each board section within the coil aperture can be reduced to thereby reduce the profile of the coil for implantation.
- the present invention provides a device for use in transcutaneous energy transfer, comprising a coil for subcutaneous placement within a human, and circuitry that is electrically connected to the coil, configured to conduct current induced in the coil.
- a major plane of the circuitry is oriented substantially perpendicular to a major plane of the coil, thereby reducing the generation of eddy currents within the circuitry while current is conducting in the coil.
- the circuitry may be located within the aperture of the coil.
- the circuitry may include substantially planar subcircuits, the planes of the subcircuits substantially located perpendicular to the major plane of the coil. Where the lines of magnetic flux are principally generated by a primary coil external to the skin, the substantially planar circuitry may be oriented substantially tangent to the lines of magnetic flux.
- the invention provides a TET system.
- the system comprises a primary coil for placement external to the skin, the coil suitable for carrying a time- varying current, and a current source arranged in series with the primary coil, comprising a power supply and power circuitry capable of delivering an electric current to the primary coil to produce magnetic flux.
- the system further comprises a secondary coil for subcutaneous placement, suitable for carrying a current induced by the magnetic flux.
- the system further comprises substantially planar conditioning circuitry that is electrically connected to the secondary coil and conducts current induced in the secondary coil, wherein the plane of the conditioning circuitry is oriented substantially perpendicular to the a major plane of the secondary coil.
- the system may further include a subcutaneous electrical device, connected to the conditiomng circuitry by one or more leads.
- the invention provides a TETS method.
- the method comprises placing a primary coil external to the skin, the primary coil being electrically coupled to a power supply capable of delivering time- varying current to the primary coil.
- the method further comprises determining the orientation of magnetic flux lines principally caused by time-varying current circulating in the primary coil in proximity to a secondary coil that will be placed beneath the skin.
- the method further includes constructing conditioning circuitry in substantially planar fashion, and orienting the plane of the conditioning circuitry so it will be substantially tangent to the lines of magnetic flux.
- FIG. 1 is a simplified conceptual diagram of a coil and magnetic flux lines.
- FIG. 2 is a simplified conceptual diagram of a two-coil configuration illustrating transcutaneous energy transfer by mutual induction.
- FIG. 3 A is a perspective diagram of a power conditioning circuit board.
- FIG. 3B is a cross-sectional view of two coils and an a power conditioning circuit board in accordance with an embodiment of the invention.
- FIG. 4 is a perspective view of a substantially planar circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 5 is a perspective view of a substantially planar circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 6 is a perspective view of a substantially planar yet curved circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 1 is a conceptual diagram depicting magnetic flux lines 10 generated when a time-varying current il (12) circulates in a closely-wound coil 14.
- Coil 14 comprises at least one turn of electrically conductive wire.
- a closely-wound coil has multiple turns, and ordinarily has the turns closely-packed such that the magnetic flux through each turn is virtually the same.
- coil 14 is not depicted in FIG. 1 as closely-wound.
- FIG. 1 shows coil 14 with a substantially circular perimeter.
- the turns of coil 14 define a center opening or aperture 17.
- Coil 14 also defines an axis 15 through the center of aperture 17, perpendicularly intersecting major coil plane 13.
- the turns of coil 14 lie substantially in major coil plane 13.
- Time- varying current il (12) is generated by a current source 16. According to the Biot-Savart Law, a magnetic field is created by a current-carrying conductor. Time- varying current il (12) circulating in coil 14 causes coil 14 to behave like a magnetic dipole, with a corresponding magnetic field represented by magnetic flux lines 10. As current il (12) varies with time, magnetic flux lines 10 vary with time as well. As shown in FIG. 1, where the lines of magnetic flux 10 pass through the major coil plane 13, the lines of magnetic flux 10 are essentially perpendicular to the major coil plane 13. In addition, magnetic flux lines 10 near the center of aperture 17 are substantially parallel to the axis 15 of coil 14.
- a thin, planar conductor 18 is depicted in FIG. 1 as near coil 14, and some of the magnetic flux lines 10 pass through the surface of conductor 18.
- the time-varying magnetic flux 10 may induce time- varying electromotive forces and time- varying currents within conductor 18, according to Faraday's Law and Lenz's Law. Such time- varying currents may be referred to as "eddy currents.”
- current i2 (20) is one of theoretically many eddy currents circulating within conductor 18.
- the shape and direction of the path of eddy current i2 (20) shown in FIG. 1 are arbitrary.
- the actual shape and direction of the eddy currents may be affected by the local shape and strength of the magnetic flux, and by whether the flux is locally increasing or decreasing.
- eddy currents may have a number of undesirable effects. For example, eddy currents produce their own time- varying magnetic fields, which may interfere with the operation of other nearby electrical or electronic elements. Also, ordinary (non-superconducting) conductors have inherent resistance to currents flowing in the conductors, and convert some of the electrical energy of eddy currents into thermal energy, or heat. Generation of excess heat may be especially detrimental in circumstances where circuitry may burn out, or in circumstances where the heat is sufficiently intense to cause a burn or other trauma to a patient's tissue. Furthermore, eddy currents generally represent an undesirable waste of energy. Eddy currents generally exist perpendicular to magnetic flux lines and depend upon the magnitude of magnetic flux flowing through the conductor. The magnetic flux is represented by flux lines 10.
- Flux lines 10 passing through coil 14 are curved, but the flux lines intersect the coil's major plane 13 at substantially right angles.
- Flux lines 10 passing through conductor 18 can be broken down into two components: a tangent component parallel to the surface of conductor 18, and a normal component perpendicular to the surface of conductor 18.
- Eddy current i2 (20) is perpendicular to the normal components of the flux lines.
- the smaller the normal components of the flux lines passing through the conductor the smaller the induced eddy currents within the conductor.
- the tangent components of flux lines 10 make no contribution to the creation of eddy currents. If the surface of the conductor 18 were tangent to flux lines 10, then only tangent components would be present, and there would be no normal component to the magnetic flux, and consequently no eddy currents would be induced.
- FIG. 2 is a conceptual diagram depicting a two-coil configuration and block diagram illustrating transfer of power through a tissue barrier 30 by mutual induction.
- a time- varying current i3 (26) is generated in a primary closely-wound coil 22 by a source 24, creating time-varying magnetic flux 28.
- Magnetic flux 28 may pass through tissue barrier 30 and may encounter a secondary, subcutaneous closely-wound coil 32.
- primary coil 22 and secondary coil 32 are not depicted in FIG. 2 as closely- wound.
- Secondary coil 32 is implanted beneath tissue barrier 30.
- the induced current i4 (34) represents a time- varying or alternating current (ac) signal that may be conditioned by conditioning circuitry 36.
- Conditioning circuitry 36 is ordinarily electrically coupled to secondary coil 32. Conditioning may include, for example, rectification of the signal, filtering of the signal, and regulation of voltage or current levels. Currents and voltages conditioned by conditioning circuitry 36 may then be used by subcutaneous electrical device 38, which is electrically coupled to conditioning circuitry 36 and is implanted beneath tissue barrier 30. Although not shown in FIG. 2, conditioning circuitry 36 may be electrically coupled to a control module that drives the device. In FIG. 2, conditioning circuitry 36 is depicted for ease of representation as a block outside the perimeter of secondary coil 32.
- conditioning circuitry 36 it may be advantageous physically to place the conditioning circuitry inside the perimeter, within the aperture of secondary coil 32.
- secondary coil 32 will be encapsulated in a casing of biocompatible material such as silicone prior to implantation, and placing conditioning circuitry 36 within the aperture of secondary coil 32 will allow the conditioning circuitry to be mounted within the aperture and to be encapsulated as well.
- Conditioning circuitry 36 may consist of electrical elements such as diodes, transistors, capacitors and resistors selected to convert the ac power from secondary coil 32 to dc power. Such circuitry can ordinarily be constructed in a substantially planar fashion, using conducting and semiconducting materials.
- the circuitry may take the form of a contiguous circuit package that includes the various electrical elements, and includes at least one terminal coupled to secondary coil 32 and at least one other terminal coupled to the control module of device 38. The dc power then is transmitted from conditioning circuitry 36 to a control module that drives implantable device 38.
- FIG. 2 illustrates one kind of transcutaneous energy transfer system.
- energy consumed by subcutaneous electrical device 38 is supplied from outside tissue barrier 30 by source 24.
- the energy is transferred through tissue barrier 30 by way of inductive coupling between primary coil 22 and secondary coil 32. It may also be said that the power, or energy per unit time, consumed by subcutaneous electrical device 38 is supplied from outside the skin by source 24.
- FIG. 3A is a perspective drawing of power conditioning circuitry 50. As shown in FIG. 3A, circuitry 50 has been constructed in a substantially planar fashion, and defines a major circuit plane 51. Most of the conducting materials in conditioning circuitry 50 lie coincident with, tangent to or parallel to major circuit plane 51.
- FIG. 3B is a cross- sectional view of a primary coil 40 and a secondary coil 42. Secondary coil 42 is implanted beneath the tissue barrier 44. The sizes and shapes of primary coil 40 and secondary coil 42 may vary.
- the axes 43 of primary coil 40 and secondary coil 42 coincide.
- a coil configuration in which the axes of the coils substantially coincide is called a "coaxial" configuration.
- the major coil plane 53 of primary coil 40 is approximately parallel to tissue barrier 44, and is also approximately parallel to the major coil plane 49 of secondary coil 42.
- axes 43 of both coils 40, 42 are approximately perpendicular to tissue barrier 44 and to major coil planes 53, 49.
- major circuit plane 51 may be approximately aligned with a diameter of secondary coil 42, substantially perpendicular to major coil plane 49 of secondary coil 42.
- conditioning circuitry 50 may be located near the center of the aperture of secondary coil 42.
- Conditioning circuitry 50 shown inside the aperture of secondary coil 42 in FIG. 3B is the same as conditioning circuitry 50 shown in FIG. 3A. Conditioning circuitry 50 is electrically coupled to secondary coil 42 by leads 48. One or more leads (not shown in
- FIG. 3B may electrically couple circuitry 50 to a subcutaneous electrical device (not shown in FIG. 3B).
- Conditioning circuitry 50 holds a substantially fixed position relative to secondary coil 42, and may be mounted within secondary coil 42 in many ways, such as by encapsulation within a casing of biocompatible material such as silicone.
- the magnetic flux lines 46 generated by passing current through primary coil 40 are generally parallel to coil axes 43 and are generally perpendicular to major coil plane 49 of secondary coil 42, especially near the center of the aperture of secondary coil 42.
- major circuit plane 51 of conditioning circuitry 50 has been oriented to be substantially parallel to coil axes 43 and perpendicular to the major coil plane 49 of secondary coil 42. Such orientation places major circuit plane 51 of conditioning circuitry 50 substantially tangent to the magnetic flux lines 46 that conditioning circuitry 50 may encounter while current is passed through primary coil 40. By being oriented substantially tangent to magnetic flux lines 46, eddy currents within conditioning circuitry 50 are minimized. Consequently, undesirable heating and energy loss due to eddy currents within conditioning circuitry 50 are minimized.
- circuitry in place of or in addition to that related to conditioning the ac signal, may be oriented within the coil in a similar manner. It is also understood that conductive materials unrelated to circuitry may be so oriented so as to minimize eddy currents and attendant heat. In some circumstances, available space considerations or other considerations may make it difficult to place all of the conditioning circuitry in a single plane. There are many possible arrangements by which the circuitry may be oriented so as to minimize eddy currents. One such example appears in FIG. 4.
- FIG. 4 is a perspective view of conditioning circuitry 52 in which circuitry has been divided into two planar subcircuits 54, 56.
- Planar subcircuits 54, 56 may be stacked in a "double-decker” fashion and may be connected by leads 58. When placed in a secondary coil such as secondary coil 42 shown in FIG. 3B, the plane of each subcircuit may be substantially tangent to the lines of magnetic flux. In a similar manner, an additional subcircuit could be added, with the subcircuits stacked in "triple-decker” fashion. Any number of subcircuits may be coupled in this way, each subcircuit substantially tangent to the lines of magnetic flux. Another example of arrangement of circuitry appears in FIG. 5, in which circuitry
- circuitry 60 is distributed among a plurality of planar subcircuits, each of which may be oriented within a secondary coil substantially tangent to the lines of magnetic flux.
- the subcircuits need not be stacked as shown in FIG. 4. Instead, the subcircuits may be arranged with interlocking circuit planes.
- FIG. 6 A further example of arrangement of circuitry appears in FIG. 6, in which the circuitry 62 is not strictly planar. As shown in FIGS. 1, 2 and 3B, lines of magnetic flux are not necessarily straight. Therefore, circuitry may be applied to a curved surface that may still be substantially tangent to the lines of magnetic flux. Although the circuitry as a whole may be curved, locally the circuitry is substantially planar and substantially tangent to the lines of magnetic flux.
- FIGS. 4, 5 and 6 are merely exemplary. There are an infinite number of ways to arrange the circuitry to make it substantially tangent to the lines of magnetic flux. A circuit designer wishing to reduce the profile of the circuitry may employ any number of ways to distribute the electrical components necessary for conditioning among two or more circuit planes. Each circuit plane may then be positioned to make the plane substantially tangent to the lines of magnetic flux.
- the designer may distribute the electrical components along one or more curved surfaces, with each surface positioned to make the circuitry locally substantially tangent to the lines of magnetic flux.
- the present invention has the advantage of flexibility of circuit design, whereby the circuit designer has a wide range of options for arrangement of circuit elements to save space or to reduce the profile of the circuitry.
- the present invention has the further advantage of reducing the effects of eddy currents within the circuitry, thereby helping avoid generation of excess heat.
- the primary and secondary coils are depicted as simple coaxial coils.
- the depiction is for illustration only, and the present invention may have a far wider-ranging application.
- the coils need not be comparably sized, as depicted in FIG. 2.
- One coil may have a substantially larger radius than the other, and instead of placing the coils one atop the other, the coils may be placed one inside the other, assuming the tissue barrier is sufficiently deformable to permit such an arrangement. In this arrangement, the coils share substantially the same major plane and the same axis.
- the coils need not be in a coaxial configuration, which is only one of many configurations that may be used for transcutaneous energy transfer.
- other TETS configurations may include cores within the coils, or may have the coils wound in a solenoid-like fashion, or may have coils composed of various kinds of wire.
- tuning the coils for maximum efficient energy transfer, or for applying particular current oscillations.
- TETS long term evolution
- many configurations for TETS involve magnetic flux, and may have the potential to create undesirable eddy currents.
- the present invention relating to orientation of the conditioning circuitry to make the circuitry substantially tangent to the lines of magnetic flux, may be applied to these other TETS configurations.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60143519T DE60143519D1 (en) | 2000-05-10 | 2001-05-10 | TRANSCUTANEOUS ENERGY TRANSMISSION WITH CIRCUIT FOR AVOIDANCE OF OVERHEATING |
EP01935288A EP1280581B1 (en) | 2000-05-10 | 2001-05-10 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
AU2001261396A AU2001261396A1 (en) | 2000-05-10 | 2001-05-10 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/567,942 US6327504B1 (en) | 2000-05-10 | 2000-05-10 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
US09/567,942 | 2000-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001085250A1 true WO2001085250A1 (en) | 2001-11-15 |
Family
ID=24269260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/015152 WO2001085250A1 (en) | 2000-05-10 | 2001-05-10 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
Country Status (5)
Country | Link |
---|---|
US (2) | US6327504B1 (en) |
EP (1) | EP1280581B1 (en) |
AU (1) | AU2001261396A1 (en) |
DE (1) | DE60143519D1 (en) |
WO (1) | WO2001085250A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007130176A1 (en) * | 2006-04-28 | 2007-11-15 | Medtronic, Inc. | Antenna for an external power source for an implantable medical device, system and method |
WO2008014022A1 (en) * | 2006-07-28 | 2008-01-31 | Boston Scientific Neuromodulation Corporation | Charger with orthogonal pcb for implantable medical device |
US7650187B2 (en) | 2003-11-18 | 2010-01-19 | DEUTSCHES ZENTRUM FüR LUFT-UND RAUMFAHRT E.V. | Assembly for wireless energy communication to an implanted device |
Families Citing this family (142)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US6850803B1 (en) * | 2000-06-16 | 2005-02-01 | Medtronic, Inc. | Implantable medical device with a recharging coil magnetic shield |
WO2003002243A2 (en) | 2001-06-27 | 2003-01-09 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US6772011B2 (en) | 2002-08-20 | 2004-08-03 | Thoratec Corporation | Transmission of information from an implanted medical device |
JP4153852B2 (en) * | 2003-09-18 | 2008-09-24 | オリンパス株式会社 | Energy supply coil and wireless in-vivo information acquisition system using the same |
US7512443B2 (en) * | 2004-04-30 | 2009-03-31 | Medtronic, Inc. | Spacers for use with transcutaneous energy transfer system |
US7374565B2 (en) * | 2004-05-28 | 2008-05-20 | Ethicon Endo-Surgery, Inc. | Bi-directional infuser pump with volume braking for hydraulically controlling an adjustable gastric band |
US7351240B2 (en) * | 2004-05-28 | 2008-04-01 | Ethicon Endo—Srugery, Inc. | Thermodynamically driven reversible infuser pump for use as a remotely controlled gastric band |
US7390294B2 (en) * | 2004-05-28 | 2008-06-24 | Ethicon Endo-Surgery, Inc. | Piezo electrically driven bellows infuser for hydraulically controlling an adjustable gastric band |
US7481763B2 (en) * | 2004-05-28 | 2009-01-27 | Ethicon Endo-Surgery, Inc. | Metal bellows position feedback for hydraulic control of an adjustable gastric band |
US7794499B2 (en) | 2004-06-08 | 2010-09-14 | Theken Disc, L.L.C. | Prosthetic intervertebral spinal disc with integral microprocessor |
US20050288740A1 (en) * | 2004-06-24 | 2005-12-29 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous telemetry to implanted medical device |
US7599744B2 (en) * | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Transcutaneous energy transfer primary coil with a high aspect ferrite core |
US7599743B2 (en) * | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous energy transfer to implanted medical device |
US7191007B2 (en) * | 2004-06-24 | 2007-03-13 | Ethicon Endo-Surgery, Inc | Spatially decoupled twin secondary coils for optimizing transcutaneous energy transfer (TET) power transfer characteristics |
US20050288739A1 (en) * | 2004-06-24 | 2005-12-29 | Ethicon, Inc. | Medical implant having closed loop transcutaneous energy transfer (TET) power transfer regulation circuitry |
US20060089709A1 (en) * | 2004-10-21 | 2006-04-27 | Helmus Michael N | Medical implant with average surface charge density |
US7191013B1 (en) | 2004-11-08 | 2007-03-13 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hand held device for wireless powering and interrogation of biomems sensors and actuators |
EP1887925A2 (en) * | 2005-05-27 | 2008-02-20 | The Cleveland Clinic Foundation | Method and apparatus for eddy current compensation in a radio frequency probe |
US7682313B2 (en) | 2005-11-23 | 2010-03-23 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US7686768B2 (en) * | 2005-11-23 | 2010-03-30 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US7738965B2 (en) * | 2006-04-28 | 2010-06-15 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
WO2008002778A2 (en) | 2006-06-29 | 2008-01-03 | Boston Scientific Limited | Medical devices with selective coating |
WO2008017028A2 (en) | 2006-08-02 | 2008-02-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
WO2008033711A2 (en) | 2006-09-14 | 2008-03-20 | Boston Scientific Limited | Medical devices with drug-eluting coating |
ES2368125T3 (en) | 2006-09-15 | 2011-11-14 | Boston Scientific Scimed, Inc. | BIOEROSIONABLE ENDOPROOTHESIS WITH BIOESTABLE INORGANIC LAYERS. |
JP2010503489A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Biodegradable endoprosthesis and method for producing the same |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
JP2010503485A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Medical device and method for manufacturing the same |
CA2663762A1 (en) | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
US20110009925A1 (en) * | 2006-10-17 | 2011-01-13 | Cochlear Limited | Transcutaneous receiving antenna device for implant |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
EP2277563B1 (en) | 2006-12-28 | 2014-06-25 | Boston Scientific Limited | Bioerodible endoprostheses and method of making the same |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
JP2010533563A (en) | 2007-07-19 | 2010-10-28 | ボストン サイエンティフィック リミテッド | Endoprosthesis with adsorption inhibiting surface |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US20090143673A1 (en) * | 2007-11-30 | 2009-06-04 | Transonic Systems Inc. | Transit time ultrasonic flow measurement |
JP2009158598A (en) * | 2007-12-25 | 2009-07-16 | Panasonic Electric Works Co Ltd | Planar coil and non-contact power transfer device using the same |
JP5581311B2 (en) | 2008-04-22 | 2014-08-27 | ボストン サイエンティフィック サイムド,インコーポレイテッド | MEDICAL DEVICE HAVING INORGANIC MATERIAL COATING AND MANUFACTURING METHOD THEREOF |
US8204602B2 (en) * | 2008-04-23 | 2012-06-19 | Medtronic, Inc. | Recharge system and method for deep or angled devices |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US8509912B2 (en) | 2008-04-30 | 2013-08-13 | Medtronic, Inc. | External power source, system and method for predicting heat loss of implantable medical device during inductive recharging by external primary coil |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US20110137391A1 (en) * | 2008-06-03 | 2011-06-09 | Leigh C Roger | Foldable coil for an implantable medical device |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
NL2001694C2 (en) * | 2008-06-18 | 2009-12-22 | Nasophlex B V | Ear stimulator for producing a stimulation signal to an ear. |
WO2009155328A2 (en) | 2008-06-18 | 2009-12-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8690749B1 (en) | 2009-11-02 | 2014-04-08 | Anthony Nunez | Wireless compressible heart pump |
WO2011119573A1 (en) | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8594806B2 (en) | 2010-04-30 | 2013-11-26 | Cyberonics, Inc. | Recharging and communication lead for an implantable device |
RU2013127313A (en) | 2010-11-16 | 2014-12-27 | Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити | SYSTEMS AND METHODS FOR TREATING A DRY EYE |
US9821159B2 (en) | 2010-11-16 | 2017-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
ES2731918T3 (en) | 2010-12-20 | 2019-11-19 | Abiomed Inc | Transcutaneous energy transfer system with multiple secondary coils |
WO2012087816A2 (en) | 2010-12-20 | 2012-06-28 | Abiomed, Inc. | Method and apparatus for accurately tracking available charge in a transcutaneous energy transfer system |
US8766788B2 (en) | 2010-12-20 | 2014-07-01 | Abiomed, Inc. | Transcutaneous energy transfer system with vibration inducing warning circuitry |
ES2927951T3 (en) | 2011-04-14 | 2022-11-14 | Abiomed Inc | Transcutaneous energy transfer coil with integrated radio frequency antenna |
US9079043B2 (en) | 2011-11-21 | 2015-07-14 | Thoratec Corporation | Transcutaneous power transmission utilizing non-planar resonators |
US9002468B2 (en) | 2011-12-16 | 2015-04-07 | Abiomed, Inc. | Automatic power regulation for transcutaneous energy transfer charging system |
US8818523B2 (en) * | 2012-04-25 | 2014-08-26 | Medtronic, Inc. | Recharge of an implantable device in the presence of other conductive objects |
AU2013272250B2 (en) | 2012-04-27 | 2015-05-21 | Med-El Elektromedizinische Geraete Gmbh | Use of defined ferromagnetic materials for optimized implant coil coupling |
US10291067B2 (en) | 2012-07-27 | 2019-05-14 | Tc1 Llc | Computer modeling for resonant power transfer systems |
WO2014018971A1 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Resonant power transfer systems with protective algorithm |
EP4257174A3 (en) | 2012-07-27 | 2023-12-27 | Tc1 Llc | Thermal management for implantable wireless power transfer systems |
US9287040B2 (en) | 2012-07-27 | 2016-03-15 | Thoratec Corporation | Self-tuning resonant power transfer systems |
WO2014018974A1 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Magnetic power transmission utilizing phased transmitter coil arrays and phased receiver coil arrays |
WO2014018973A1 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Resonant power transmission coils and systems |
WO2014018969A2 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Resonant power transfer system and method of estimating system state |
US10383990B2 (en) | 2012-07-27 | 2019-08-20 | Tc1 Llc | Variable capacitor for resonant power transfer systems |
US9343923B2 (en) | 2012-08-23 | 2016-05-17 | Cyberonics, Inc. | Implantable medical device with backscatter signal based communication |
US9935498B2 (en) | 2012-09-25 | 2018-04-03 | Cyberonics, Inc. | Communication efficiency with an implantable medical device using a circulator and a backscatter signal |
WO2014138709A1 (en) | 2013-03-08 | 2014-09-12 | Oculeve, Inc. | Devices and methods for treating dry eye in animals |
US9717627B2 (en) | 2013-03-12 | 2017-08-01 | Oculeve, Inc. | Implant delivery devices, systems, and methods |
WO2014145895A1 (en) | 2013-03-15 | 2014-09-18 | Thoratec Corporation | Malleable tets coil with improved anatomical fit |
WO2014145664A1 (en) | 2013-03-15 | 2014-09-18 | Thoratec Corporation | Integrated implantable tets housing including fins and coil loops |
JP6298145B2 (en) | 2013-03-15 | 2018-03-20 | アルフレッド イー. マン ファウンデーション フォー サイエンティフィック リサーチ | Current sensing multiple output current stimulator with fast turn-on time |
NZ704579A (en) | 2013-04-19 | 2018-10-26 | Oculeve Inc | Nasal stimulation devices and methods |
CA2919474C (en) | 2013-07-29 | 2020-05-05 | Alfred E. Mann Foundation For Scientific Research | Microprocessor controlled class e driver |
EP3069358B1 (en) | 2013-11-11 | 2019-06-12 | Tc1 Llc | Hinged resonant power transfer coil |
US10615642B2 (en) | 2013-11-11 | 2020-04-07 | Tc1 Llc | Resonant power transfer systems with communications |
EP3072211A4 (en) | 2013-11-11 | 2017-07-05 | Thoratec Corporation | Resonant power transfer systems with communications |
US9770583B2 (en) | 2014-02-25 | 2017-09-26 | Oculeve, Inc. | Polymer formulations for nasolacrimal stimulation |
US10610692B2 (en) | 2014-03-06 | 2020-04-07 | Tc1 Llc | Electrical connectors for implantable devices |
EP3673952A1 (en) | 2014-07-25 | 2020-07-01 | Oculeve, Inc. | Stimulation patterns for treating dry eye |
AU2015301402B2 (en) | 2014-08-15 | 2020-06-04 | Axonics Modulation Technologies, Inc. | Integrated electromyographic clinician programmer for use with an implantable neurostimulator |
WO2016025912A1 (en) | 2014-08-15 | 2016-02-18 | Axonics Modulation Technologies, Inc. | Systems and methods for neurostimulation electrode configurations based on neural localization |
EP3180070B1 (en) | 2014-08-15 | 2021-04-14 | Axonics Modulation Technologies, Inc. | Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indications |
WO2016025913A1 (en) | 2014-08-15 | 2016-02-18 | Axonics Modulation Technologies, Inc. | Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder |
WO2016025909A1 (en) | 2014-08-15 | 2016-02-18 | Axonics Modulation Technologies, Inc. | External pulse generator device and associated methods for trial nerve stimulation |
US10186760B2 (en) | 2014-09-22 | 2019-01-22 | Tc1 Llc | Antenna designs for communication between a wirelessly powered implant to an external device outside the body |
US9583874B2 (en) | 2014-10-06 | 2017-02-28 | Thoratec Corporation | Multiaxial connector for implantable devices |
US10207108B2 (en) | 2014-10-22 | 2019-02-19 | Oculeve, Inc. | Implantable nasal stimulator systems and methods |
CA2965514A1 (en) | 2014-10-22 | 2016-04-28 | Oculeve, Inc. | Contact lens for increasing tear production |
CN107106843A (en) | 2014-10-22 | 2017-08-29 | 奥库利维公司 | Stimulating apparatus and method for treating xerophthalmia |
ES2729702T3 (en) | 2015-01-09 | 2019-11-05 | Axonics Modulation Tech Inc | Enhanced antenna and use procedures for an implantable nerve stimulator |
EP3242721B1 (en) | 2015-01-09 | 2019-09-18 | Axonics Modulation Technologies, Inc. | Attachment devices and associated methods of use with a nerve stimulation charging device |
WO2016112398A1 (en) | 2015-01-09 | 2016-07-14 | Axonics Modulation Technologies, Inc. | Patient remote and associated methods of use with a nerve stimulation system |
CA2991903C (en) | 2015-07-10 | 2023-10-17 | Axonics Modulation Technologies, Inc. | Implantable nerve stimulator having internal electronics without asic and methods of use |
US10148126B2 (en) | 2015-08-31 | 2018-12-04 | Tc1 Llc | Wireless energy transfer system and wearables |
WO2017062552A1 (en) | 2015-10-07 | 2017-04-13 | Tc1 Llc | Resonant power transfer systems having efficiency optimization based on receiver impedance |
US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
JP6876363B2 (en) | 2016-01-29 | 2021-05-26 | アクソニクス モジュレーション テクノロジーズ インコーポレイテッド | Methods and systems for frequency adjustment that optimize the charging of implantable neurostimulators |
CN108697897B (en) | 2016-02-12 | 2023-01-13 | 艾克索尼克斯股份有限公司 | External pulse generator apparatus for testing neural stimulation and associated methods |
US10252048B2 (en) | 2016-02-19 | 2019-04-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
AU2017260237A1 (en) | 2016-05-02 | 2018-11-22 | Oculeve, Inc. | Intranasal stimulation for treatment of meibomian gland disease and blepharitis |
EP3497775B1 (en) | 2016-09-21 | 2022-07-13 | Tc1 Llc | Systems and methods for locating implanted wireless power transmission devices |
CN110022755A (en) | 2016-12-02 | 2019-07-16 | 奥库利维公司 | Device and method for xerophthalmia prediction and treatment recommendations |
US11197990B2 (en) | 2017-01-18 | 2021-12-14 | Tc1 Llc | Systems and methods for transcutaneous power transfer using microneedles |
WO2018226991A1 (en) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
WO2019135890A1 (en) | 2018-01-04 | 2019-07-11 | Tc1 Llc | Systems and methods for elastic wireless power transmission devices |
US10722631B2 (en) | 2018-02-01 | 2020-07-28 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
CA3090810A1 (en) | 2018-02-22 | 2019-08-29 | Axonics Modulation Technologies, Inc. | Neurostimulation leads for trial nerve stimulation and methods of use |
WO2020185902A1 (en) | 2019-03-11 | 2020-09-17 | Axonics Modulation Technologies, Inc. | Charging device with off-center coil |
US11439829B2 (en) | 2019-05-24 | 2022-09-13 | Axonics, Inc. | Clinician programmer methods and systems for maintaining target operating temperatures |
WO2020242900A1 (en) | 2019-05-24 | 2020-12-03 | Axonics Modulation Technologies, Inc. | Trainer device for a neurostimulator programmer and associated methods of use with a neurostimulation system |
JP2022540616A (en) | 2019-07-12 | 2022-09-16 | シファメド・ホールディングス・エルエルシー | Intravascular blood pump and methods of manufacture and use |
US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
WO2021062265A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4665896A (en) * | 1985-07-22 | 1987-05-19 | Novacor Medical Corporation | Power supply for body implant and method of use |
US5350413A (en) * | 1990-06-21 | 1994-09-27 | The University Of Ottawa | Transcutaneous energy transfer device |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52151835A (en) | 1976-04-30 | 1977-12-16 | Univ Johns Hopkins | Enclosed battery |
US4143661A (en) | 1977-12-12 | 1979-03-13 | Andros Incorporated | Power supply for body implant and method for operation |
JPS56106663A (en) | 1980-01-31 | 1981-08-25 | Tokyo Shibaura Electric Co | Transmitting medium for energy to organism buried device |
US4441498A (en) | 1982-05-10 | 1984-04-10 | Cardio-Pace Medical, Inc. | Planar receiver antenna coil for programmable electromedical pulse generator |
US5876425A (en) | 1989-09-22 | 1999-03-02 | Advanced Bionics Corporation | Power control loop for implantable tissue stimulator |
CA2007439C (en) * | 1990-01-09 | 1996-08-13 | John Miller | Transcutaneous energy transfer device |
US5109843A (en) | 1990-11-30 | 1992-05-05 | University Of Cincinnati | Extra to-intracorporeal power supply |
DE4104359A1 (en) | 1991-02-13 | 1992-08-20 | Implex Gmbh | CHARGING SYSTEM FOR IMPLANTABLE HOERHILFEN AND TINNITUS MASKERS |
US5314453A (en) | 1991-12-06 | 1994-05-24 | Spinal Cord Society | Position sensitive power transfer antenna |
US5193540A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5193539A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5676651A (en) | 1992-08-06 | 1997-10-14 | Electric Boat Corporation | Surgically implantable pump arrangement and method for pumping body fluids |
US5591217A (en) | 1995-01-04 | 1997-01-07 | Plexus, Inc. | Implantable stimulator with replenishable, high value capacitive power source and method therefor |
US5702431A (en) | 1995-06-07 | 1997-12-30 | Sulzer Intermedics Inc. | Enhanced transcutaneous recharging system for battery powered implantable medical device |
US5690693A (en) | 1995-06-07 | 1997-11-25 | Sulzer Intermedics Inc. | Transcutaneous energy transmission circuit for implantable medical device |
US5891183A (en) | 1996-06-04 | 1999-04-06 | Med-El Elektromedizinische Gerate Ges.M.B.H. | Device for transferring electromagnetic energy between primary and secondary coils |
US5755748A (en) | 1996-07-24 | 1998-05-26 | Dew Engineering & Development Limited | Transcutaneous energy transfer device |
US5733313A (en) | 1996-08-01 | 1998-03-31 | Exonix Corporation | RF coupled, implantable medical device with rechargeable back-up power source |
US5715837A (en) | 1996-08-29 | 1998-02-10 | Light Sciences Limited Partnership | Transcutaneous electromagnetic energy transfer |
US5713939A (en) | 1996-09-16 | 1998-02-03 | Sulzer Intermedics Inc. | Data communication system for control of transcutaneous energy transmission to an implantable medical device |
US5749909A (en) | 1996-11-07 | 1998-05-12 | Sulzer Intermedics Inc. | Transcutaneous energy coupling using piezoelectric device |
US5741316A (en) | 1996-12-02 | 1998-04-21 | Light Sciences Limited Partnership | Electromagnetic coil configurations for power transmission through tissue |
ES2224420T3 (en) * | 1997-08-01 | 2005-03-01 | Alfred E. Mann Foundation For Scientific Research | IMPLANTABLE DEVICE WITH IMPROVED POWER AND BATTERY RECHARGE CONFIGURATION. |
US5945762A (en) | 1998-02-10 | 1999-08-31 | Light Sciences Limited Partnership | Movable magnet transmitter for inducing electrical current in an implanted coil |
US5948006A (en) | 1998-10-14 | 1999-09-07 | Advanced Bionics Corporation | Transcutaneous transmission patch |
-
2000
- 2000-05-10 US US09/567,942 patent/US6327504B1/en not_active Expired - Lifetime
-
2001
- 2001-05-10 EP EP01935288A patent/EP1280581B1/en not_active Expired - Lifetime
- 2001-05-10 DE DE60143519T patent/DE60143519D1/en not_active Expired - Lifetime
- 2001-05-10 AU AU2001261396A patent/AU2001261396A1/en not_active Abandoned
- 2001-05-10 WO PCT/US2001/015152 patent/WO2001085250A1/en active Application Filing
- 2001-12-04 US US10/004,731 patent/US20020123777A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4665896A (en) * | 1985-07-22 | 1987-05-19 | Novacor Medical Corporation | Power supply for body implant and method of use |
US5350413A (en) * | 1990-06-21 | 1994-09-27 | The University Of Ottawa | Transcutaneous energy transfer device |
US5350413B1 (en) * | 1990-06-21 | 1999-09-07 | Heart Inst Research Corp | Transcutaneous energy transfer device |
Non-Patent Citations (1)
Title |
---|
See also references of EP1280581A4 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7650187B2 (en) | 2003-11-18 | 2010-01-19 | DEUTSCHES ZENTRUM FüR LUFT-UND RAUMFAHRT E.V. | Assembly for wireless energy communication to an implanted device |
DE10353943B4 (en) * | 2003-11-18 | 2013-01-03 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Arrangement for the wireless transmission of energy to an implanted device |
WO2007130176A1 (en) * | 2006-04-28 | 2007-11-15 | Medtronic, Inc. | Antenna for an external power source for an implantable medical device, system and method |
US7848814B2 (en) | 2006-04-28 | 2010-12-07 | Medtronic, Inc. | System for transcutaneous energy transfer to an implantable medical device with mating elements |
US7962211B2 (en) | 2006-04-28 | 2011-06-14 | Medtronic, Inc. | Antenna for an external power source for an implantable medical device, system and method |
WO2008014022A1 (en) * | 2006-07-28 | 2008-01-31 | Boston Scientific Neuromodulation Corporation | Charger with orthogonal pcb for implantable medical device |
US9002445B2 (en) | 2006-07-28 | 2015-04-07 | Boston Scientific Neuromodulation Corporation | Charger with orthogonal PCB for implantable medical device |
US9333367B2 (en) | 2006-07-28 | 2016-05-10 | Boston Scientific Neuromodulation Corporation | Charger with orthogonal PCB for implantable medical device |
Also Published As
Publication number | Publication date |
---|---|
US20020123777A1 (en) | 2002-09-05 |
US6327504B1 (en) | 2001-12-04 |
AU2001261396A1 (en) | 2001-11-20 |
DE60143519D1 (en) | 2011-01-05 |
EP1280581B1 (en) | 2010-11-24 |
EP1280581A4 (en) | 2009-09-30 |
EP1280581A1 (en) | 2003-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6327504B1 (en) | Transcutaneous energy transfer with circuitry arranged to avoid overheating | |
AU2017210564B2 (en) | Medical device communication and charging assemblies for use with implantable signal generators | |
US9636508B2 (en) | Inductive charger with magnetic shielding | |
US9333367B2 (en) | Charger with orthogonal PCB for implantable medical device | |
US20190314564A1 (en) | Transcutaneous energy transfer systems | |
JP5701363B2 (en) | Alignment indicator for smart charger | |
US20130304158A1 (en) | Transcutaneous energy transfer module with integrated conversion circuity | |
US20080027513A1 (en) | Systems And Methods For Using A Butterfly Coil To Communicate With Or Transfer Power To An Implantable Medical Device | |
US20140114373A1 (en) | Intermediate Coupler to Facilitate Charging in an Implantable Medical Device System | |
Tang | A low-operating-voltage wireless intermediate-range scheme for energy and signal transmission by magnetic coupling for implantable devices | |
AU2013272250A1 (en) | Use of defined ferromagnetic materials for optimized implant coil coupling | |
US20170361110A1 (en) | Multi-Conductor Cable in an External Charger for an Implantable Medical Device | |
Agarkar et al. | Variable Frequency on Wireless Power Transfer for Pacemaker using Embedded Technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001935288 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001935288 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |